Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | MEDP | IDXX |
|---|---|---|
| Price | $608.09 | $522.76 |
| Change today | ▼ 2.58% | ▲ 0.11% |
| Market cap | $16.97B | $41.18B |
| Return, 3 months | – | – |
| Return, year to date | – | – |
| Return, 1 year | – | – |
| P/E (TTM) | 35.7 | 36.7 |
| P/B | 39.1 | 25.5 |
| P/E percentile vs own 5y | – | 2nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +9.7% |
| Net profit growth (YoY) | – | +15.1% |
| Gross margin | – | 62.4% |
| Operating margin | – | 32.0% |
| Net margin | – | 25.0% |
| Return on equity | – | 74.2% |
| Analyst target vs. price | +3.6% | +33.7% |
| Analyst buy share | 22% | 57% |
| RSI (14) | – | – |
| 30-day volatility | – | – |
| Max drawdown, 1 year | – | – |
| Trend read | – | – |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
